The aim of this study was to determine if there are any changes in adiponectin and omentin levels in GDM patients who delivered at term and preterm and to evaluate whether adipokines can be useful as a clinical biomarker to predict subsequent preterm delivery. This evidence concerns the gene ITLN1 and gestational diabetes.